The medical market in Uzbekistan faces significant demand gaps and relies heavily on imports, indicating substantial potential for development. Therefore, enterprises that value the Central Asian medical market are strategically planning to enter Uzbekistan's medical market.
The TIHE 2024 took place in Tashkent, Uzbekistan, from April 16th to 18th, 2024. TIHE is a well-known healthcare exhibition in Central Asia, greatly contributing to the development of Uzbekistan and Central Asia's healthcare industry. It has also positioned Central Asia as one of the most promising medical markets. Alongside the exhibition, high-level medical talks between China and Uzbekistan were helad, as well as precise economic and trade matchmaking sessions, and specialized industry forums such as pharmaceutical equipment cooperation forums and medical device cooperation forums. These events aim to accurately understand Uzbekistan's latest market trends, policies, and potential cooperative projects, establish government partnerships, and build networking resources. The focus is on facilitating economic and trade negotiations, promoting product trade procurement, implementing product agency agreements, establishing offices, technology transfer collaborations, and cooperative factory construction.
With the aim of promoting Singclean Medical’s medical products and enhancing its brand influence, our sales manager for Central Asia attended TIHE 2024. During the event, our team introduced Singclean’s comprehensive range of products and showcased our latest developments to local customers. This included Singfiller and Singderm, our cross-linked hyaluronic acid dermal fillers for plastic surgery, Singclean IVD test kits, Singclean medical sodium hyaluronate gel for surgeries, Surgiclean absorbable hemostatic products, SKformula skin care products, and more. Our participation in TIHE provided an excellent platform to engage with potential clients, strengthen existing partnerships, and establish Singclean Medical as a leading provider of high-quality medical solutions in the Central Asian market.
We especially introduced Singfiller bi-phasic hyaluronic acid dermal filler and Singderm mono-phasic hyaluronic acid dermal filler to local customers. Also, our new arrival Singderm PLLA injection attracted many people’s attention. With PLLA as the core ingredient, it can be injected in to skin and stimulate the regeneration of collagen to achieve the effects of rejuvenation for about 18 to 24 months! As Singclean Medical is putting more effort into developing medical beauty products, we will provide more effective and safe plastic surgery solution for Central Asia people!
Participating in the TIHE 2024 is a very meaningful experience for our company. We appreciate the exhibition providing us with the valuable opportunity to gain an in-depth understanding of local market needs. Through the exhibition, we not only deepened our understanding of the Uzbekistan market, but also expanded cooperation channels with local enterprises, laying a solid foundation for future development in the region.
